Matteo Vergassola Selected Research

Matteo Vergassola Research Topics

2	Wounds and Injuries (Trauma) 04/2023 - 01/2022
1	Hyperhidrosis 01/2023
1	Neuroblastoma 01/2023
1	Pain (Aches) 01/2023
1	Memory Disorders (Memory Loss) 01/2022
1	Schizophrenia (Dementia Praecox) 12/2020
1	Absence Epilepsy (Childhood Absence Epilepsy) 11/2020
1	Autoimmune Diseases (Autoimmune Disease) 09/2019

2	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2023 - 01/2022
1	Matrix Metalloproteinases (MMPs)IBA 04/2023
1	Sodium Hypochlorite (Clorox)IBA 04/2023
1	SolutionsIBA 04/2023
1	AntiperspirantsIBA 01/2023
1	Analgesics (Analgesic Drugs)IBA 01/2023
1	Benzydamine (Tantum)IBA 01/2023
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2023
1	Amyloid beta-PeptidesIBA 01/2022
1	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2022
1	phosphatidylethanolamineIBA 01/2022
1	glycerophosphoethanolamineIBA 01/2022
1	cinnabarinic acidIBA 12/2020
1	Antipsychotic Agents (Antipsychotics)IBA 12/2020
1	KynurenineIBA 12/2020
1	N- cyclobutyl- 6- ((3- fluorophenyl)ethynyl)nicotinamideIBA 11/2020
1	N-Methylaspartate (NMDA)IBA 09/2019
1	AutoreceptorsIBA 09/2019
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 09/2019

1	Injections 01/2023